Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Circulating tumor DNA (ctDNA) has offered a minimally invasive and feasible approach for detection of EGFR mutation for non-small cell lung cancer (NSCLC). This meta-analysis was designed to investigate the diagnostic value of ctDNA, compared with current "gold standard," tumor tissues.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cancer Epidemiol Biomarkers Prev

Title: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Publisher: American Association for Cancer Research (AACR)

ISSN (Electronic): 1538-7755

ISSN (Print): 1055-9965

Publication date (Electronic): Jan 2015

Volume: 24

Issue: 1

Affiliations

[1 ] Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China. Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China. Fourth Clinical College of Nanjing Medical University, Nanjing, China.

[2 ] Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China. Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China.

[3 ] Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China. Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China. First Clinical College of Nanjing Medical University, Nanjing, China.

[4 ] Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China. Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China. xulin83cn@gmail.com yinhero001@126.com.

Article

Publisher Item ID: 1055-9965.EPI-14-0895

DOI: 10.1158/1055-9965.EPI-14-0895

PubMed ID: 25339418

SO-VID: 5acc6cf0-e6ef-4eca-9220-032f663d128c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 70

See all cited by

- Version 1